This is the definitive reference covering drug therapy of cardiovascular conditions! This comprehensive text describes both current and future developments regarding drug therapy for all cardiovascular diseases. It is updated to cover the latest basic science information, drugs in development, and molecular biological advances. An in-depth review of all the cardiovascular agents currently on the market is also included.
Indice testuale
Part 1 Introductory Chapters 1.* Basic Principles 2.* Placebo Effect 3.* Compliance 4.* New Drug Development 5.* Pharmacoeconomics 6.* Cardiovascular Pharm History Part 2 Drug Classes 7. Alpha & Beta blockers 8. Cholinergic & Anticholinergic Drugs 9. Calcium blockers 10. RAS -- ACE, ARBs 11. Diuretic 12. Mag, K+, Calcium 13. Digitalis and Inotropic Agents 14.* Organic Nitrates and nitroprusside 15.* Central Action, Ganglionic blockers, neuron depletors 16.* Nonspecific antihypertensive vasodilators 17. Antiarrhythmics 18.* Antiplatelets & Antithrombotics 19.* Thrombolytics 20. Lipid lowering/effects of CV drugs on lipoproteins 21.* Combination 22.* Smoking, nicotine 23. Fish oils 24. Antioxidant vitamins and free radical scavengers 25.* Prostacyclin 26. Dopamine Part 3 New Drugs Classes in Development 27. Natriuretic peptides and neutral endopeptidase 28.* Potassium channel and sodium-hydrogen channel 29.* Serotonin 30.* Imidazoline 31*. Endothelin 32.* Adenosine 33.* Nitric oxide 34.* Renin 35.* Vasopressin 36.* Hormones 37.* Innovative approaches for myocardial ischemia -- focus on angiogenesis 38.* Angiogenesis 39.* Innovative drug targets 40. Restenosis 41.* Gene therapy 42. Apoptosis 43.* Matrix Metalloproteinase 44. NSAIDS & Cox 2 inhibitors 45. Prostaglandins & P450 Metabolites 46.* Innovative med. approaches to hyperlipidemia
